Protagonist Therapeutics (PTGX) Fair Value & DCF
PTGX$130.95-3.43 -2.55%
Market cap$8.55BEnterprise value$8.28BRevenue (TTM)$551.69MMarket position—
Score
68
Bullish
Value
34
Quality
77
Growth
93
Protagonist Therapeutics, Inc. (PTGX) trades at $130.95 on $8.55B of equity value, with a trailing P/E of 24.97. Fair value on Stocklytics blends discounted cash flow and an earnings-based cross-check when the saved model is on file. The price and ratio here are from the live quote.